Stocktoria
Olema Pharmaceuticals, Inc. OLMA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-11-19
Chart by TradingView
1/9
Piotroski F — financial health
8.96
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$178.7M | -$142.3M | -$105.0M | -$107.0M | -$71.5M |
| Net income | -$162.5M | -$129.5M | -$96.7M | -$104.8M | -$71.1M |
| Operating cash flow | -$146.7M | -$104.4M | -$83.7M | -$82.1M | -$50.7M |
| Free cash flow | — | -$104.5M | — | -$82.4M | -$52.3M |
| Total assets | $533.4M | $451.0M | $276.9M | $215.6M | $295.9M |
| Total liabilities | $54.9M | $42.0M | $23.1M | $18.1M | $11.4M |
| Shareholders' equity | $478.6M | $409.0M | $253.9M | $197.5M | $284.6M |
| Ratios | |||||
| Return on assets | -30.5% | -28.7% | -34.9% | -48.6% | -24.0% |
| Return on equity | -33.9% | -31.7% | -38.1% | -53.0% | -25.0% |
| Current ratio | 9.95 | 10.50 | 12.33 | 12.62 | 32.23 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 109,707 | $1.6M |
| Duquesne Family Office LLC | 986,827 | $14,714 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 8.96 (safe)
- Working capital / assets 0.869
- Retained earnings / assets -1.12
- EBIT / assets -0.335
- Equity / liabilities 8.722
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001750284 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.